Human iPSC-derived neurons reveal early developmental alteration of neurite outgrowth in the late-occurring neurodegenerative Wolfram syndrome.

[1]  T. Hershey,et al.  Developmental hypomyelination in Wolfram syndrome: new insights from neuroimaging and gene expression analyses , 2019, Orphanet Journal of Rare Diseases.

[2]  Robin J. Vigouroux,et al.  Construction and reconstruction of brain circuits: normal and pathological axon guidance , 2019, Journal of neurochemistry.

[3]  A. Terasmaa,et al.  GLP-1 receptor agonist liraglutide has a neuroprotective effect on an aged rat model of Wolfram syndrome , 2019, Scientific Reports.

[4]  F. Urano,et al.  Current Landscape of Treatments for Wolfram Syndrome. , 2019, Trends in pharmacological sciences.

[5]  U. Grohmann,et al.  Wolfram syndrome, a rare neurodegenerative disease: from pathogenesis to future treatment perspectives , 2019, Journal of Translational Medicine.

[6]  C. Hetz,et al.  Pharmacological targeting of the unfolded protein response for disease intervention , 2019, Nature Chemical Biology.

[7]  J. Shimony,et al.  Evidence for altered neurodevelopment and neurodegeneration in Wolfram syndrome using longitudinal morphometry , 2019, Scientific Reports.

[8]  Sander Greenland,et al.  Scientists rise up against statistical significance , 2019, Nature.

[9]  A. Zahradníková,et al.  Calcium Signaling and Contractility in Cardiac Myocyte of Wolframin Deficient Rats , 2019, Front. Physiol..

[10]  K. Sango,et al.  CMT type 2N disease-associated AARS mutant inhibits neurite growth that can be reversed by valproic acid , 2019, Neuroscience Research.

[11]  S. Seino,et al.  Activation of GLP-1 receptor signalling alleviates cellular stresses and improves beta cell function in a mouse model of Wolfram syndrome , 2018, Diabetologia.

[12]  J. Schwamborn.  Is Parkinson's Disease a Neurodevelopmental Disorder and Will Brain Organoids Help Us to Understand It? , 2018, Stem cells and development.

[13]  A. Dagher,et al.  Mesocorticolimbic Connectivity and Volumetric Alterations in DCC Mutation Carriers , 2018, The Journal of Neuroscience.

[14]  Yasufumi Sakakibara,et al.  Knockdown of wfs1, a fly homolog of Wolfram syndrome 1, in the nervous system increases susceptibility to age- and stress-induced neuronal dysfunction and degeneration in Drosophila , 2018, PLoS genetics.

[15]  M. Hickey,et al.  Wfs1- deficient rats develop primary symptoms of Wolfram syndrome: insulin-dependent diabetes, optic nerve atrophy and medullary degeneration , 2017, Scientific Reports.

[16]  Hongyu Zhang,et al.  Valproate Attenuates Endoplasmic Reticulum Stress-Induced Apoptosis in SH-SY5Y Cells via the AKT/GSK3β Signaling Pathway , 2017, International journal of molecular sciences.

[17]  E. Stoeckli.  Where does axon guidance lead us? , 2017, F1000Research.

[18]  P. Walter,et al.  Ceapins inhibit ATF6α signaling by selectively preventing transport of ATF6α to the Golgi apparatus during ER stress , 2016, eLife.

[19]  V. Choubey,et al.  Role of Mitochondrial Dynamics in Neuronal Development: Mechanism for Wolfram Syndrome , 2016, PLoS biology.

[20]  T. Bourgeron,et al.  Human Pluripotent Stem Cell-derived Cortical Neurons for High Throughput Medication Screening in Autism: A Proof of Concept Study in SHANK3 Haploinsufficiency Syndrome , 2016, EBioMedicine.

[21]  Andrew D. Rouillard,et al.  Enrichr: a comprehensive gene set enrichment analysis web server 2016 update , 2016, Nucleic Acids Res..

[22]  L. Tychsen,et al.  Neuroimaging evidence of deficient axon myelination in Wolfram syndrome , 2016, Scientific Reports.

[23]  D. Arnett,et al.  Comprehensive evaluation of AmpliSeq transcriptome, a novel targeted whole transcriptome RNA sequencing methodology for global gene expression analysis , 2015, BMC Genomics.

[24]  Ian F. Harrison,et al.  Neurorestoration induced by the HDAC inhibitor sodium valproate in the lactacystin model of Parkinson's is associated with histone acetylation and up‐regulation of neurotrophic factors , 2015, British journal of pharmacology.

[25]  E. Barbier,et al.  Microtubule-associated protein 6 mediates neuronal connectivity through Semaphorin 3E-dependent signalling for axonal growth , 2015, Nature Communications.

[26]  Xuebing Ding,et al.  Valproate Attenuates 25-kDa C-Terminal Fragment of TDP-43-Induced Neuronal Toxicity via Suppressing Endoplasmic Reticulum Stress and Activating Autophagy , 2015, International journal of biological sciences.

[27]  S. Brignani,et al.  Axon guidance proteins in neurological disorders , 2015, The Lancet Neurology.

[28]  Michael W. Weiner,et al.  Genome-wide interaction analysis reveals replicated epistatic effects on brain structure , 2015, Neurobiology of Aging.

[29]  Tianci Chu,et al.  Valproic acid-mediated neuroprotection and neurogenesis after spinal cord injury: from mechanism to clinical potential. , 2015, Regenerative medicine.

[30]  F. Urano,et al.  A calcium-dependent protease as a potential therapeutic target for Wolfram syndrome , 2014, Proceedings of the National Academy of Sciences.

[31]  W. Chung,et al.  β-Cell Dysfunction Due to Increased ER Stress in a Stem Cell Model of Wolfram Syndrome , 2014, Diabetes.

[32]  F. Urano.  Wolfram Syndrome iPS Cells: The First Human Cell Model of Endoplasmic Reticulum Disease , 2014, Diabetes.

[33]  T. Marquardt,et al.  What axons tell each other: axon–axon signaling in nerve and circuit assembly , 2013, Current Opinion in Neurobiology.

[34]  S. Mehta,et al.  Axonal fasciculation and the role of polysialic acid‐neural cell adhesion molecule in rat cortical neurons , 2013, Journal of neuroscience research.

[35]  T. Bourgeron,et al.  Differentiation from human pluripotent stem cells of cortical neurons of the superficial layers amenable to psychiatric disease modeling and high-throughput drug screening , 2013, Translational Psychiatry.

[36]  Edward Y. Chen,et al.  Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool , 2013, BMC Bioinformatics.

[37]  Z. Nagy,et al.  Vacuolar-type H+-ATPase V1A subunit is a molecular partner of Wolfram syndrome 1 (WFS1) protein, which regulates its expression and stability. , 2013, Human molecular genetics.

[38]  M. Permutt,et al.  Early Brain Vulnerability in Wolfram Syndrome , 2012, PloS one.

[39]  M. Peschanski,et al.  miR-125 potentiates early neural specification of human embryonic stem cells , 2012, Development.

[40]  G. Salzano,et al.  Diabetes and Neurodegeneration in Wolfram Syndrome , 2011, Diabetes Care.

[41]  S. A. E. Mkadem,et al.  Neurologic features and genotype‐phenotype correlation in Wolfram syndrome , 2011, Annals of neurology.

[42]  A. Tanoue,et al.  The mood stabilizer valproic acid improves defective neurite formation caused by charcot‐marie‐tooth disease‐associated mutant Rab7 through the JNK signaling pathway , 2010, Journal of neuroscience research.

[43]  M. Permutt,et al.  Wolfram syndrome 1 gene negatively regulates ER stress signaling in rodent and human cells. , 2010, The Journal of clinical investigation.

[44]  E. Engle,et al.  Human genetic disorders of axon guidance. , 2010, Cold Spring Harbor perspectives in biology.

[45]  I. Takasaki,et al.  Valproic acid induces up- or down-regulation of gene expression responsible for the neuronal excitation and inhibition in rat cortical neurons through its epigenetic actions , 2009, Neuroscience Research.

[46]  R. Stewart,et al.  Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences , 2009, Science.

[47]  M. Tomishima,et al.  Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling , 2009, Nature Biotechnology.

[48]  Ling Lin,et al.  Axon guidance and synaptic maintenance: preclinical markers for neurodegenerative disease and therapeutics , 2009, Trends in Neurosciences.

[49]  Kathryn L. Lipson,et al.  WFS1 Is a Novel Component of the Unfolded Protein Response and Maintains Homeostasis of the Endoplasmic Reticulum in Pancreatic β-Cells* , 2005, Journal of Biological Chemistry.

[50]  D. Ginty,et al.  Functions and mechanisms of retrograde neurotrophin signalling , 2005, Nature Reviews Neuroscience.

[51]  Yoshifumi Watanabe,et al.  WFS1 (Wolfram syndrome 1) gene product: predominant subcellular localization to endoplasmic reticulum in cultured cells and neuronal expression in rat brain. , 2001, Human molecular genetics.

[52]  P. Shannon,et al.  Evidence of widespread axonal pathology in Wolfram syndrome , 1999, Acta Neuropathologica.

[53]  C. Shaw,et al.  Wolfram syndrome: Hereditary diabetes mellitus with brainstem and optic atrophy , 1996, Annals of neurology.

[54]  T. Barrett,et al.  Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome , 1995, The Lancet.

[55]  U. Slager,et al.  Simultaneous occurrence of diabetes mellitus, diabetes insipidus, and optic atrophy in a brother and sister. , 1977, American journal of diseases of children.